Segment Information

12 Months Ended

Jun. 30, 2015

Segment Reporting [Abstract]

Segment Information

(19) Segment Information

The Company’s business is organized along product lines into three principal segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals.

Human Health - includes finished dosage form generic drugs and nutraceutical products.

Pharmaceutical Ingredients – includes pharmaceutical intermediates and active pharmaceutical ingredients (“APIs”).

Performance Chemicals - The Performance Chemicals segment is made up of two product groups: Specialty Chemicals and Agriculture Protection Products. Specialty chemicals includes a variety of chemicals which make plastics, surface coatings, textiles, fuels and lubricants perform to their designed capabilities. Dye and pigment intermediates are used in the color-producing industries such as textiles, inks, paper, and coatings. Organic intermediates are used in the production of agrochemicals. In addition, Aceto is a supplier of diazos and couplers to the paper, film and electronics industries.

Agricultural Protection Products includes herbicides, fungicides and insecticides that control weed growth as well as control the spread of insects and other microorganisms that can severely damage plant growth. The Agricultural Protection Products segment also includes a sprout inhibitor for potatoes and an herbicide for sugar cane.

The Company’s chief operating decision maker evaluates performance of the segments based on net sales, gross profit and income before income taxes. Unallocated corporate amounts are deemed by the Company as administrative, oversight costs, not managed by the segment managers. The Company does not allocate assets by segment because the chief operating decision maker does not review the assets by segment to assess the segments’ performance, as the assets are managed on an entity-wide basis. During all periods presented, our chief operating decision maker has been the Chief Executive Officer of the Company. In accordance with GAAP, the Company has aggregated certain operating segments into reportable segments because they have similar economic characteristics, and the operating segments are similar in all of the following areas: (a) the nature of the products and services; (b) the nature of the production processes; (c) the type or class of customer for their products and services; (d) the methods used to distribute their products or provide their services; and (e) the nature of the regulatory environment.

	Human  Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2015
Net sales	$	225,263	$	149,296	$	172,392	$	-		$	546,951
Gross profit		75,749		26,683		33,002		-			135,434
Income before income taxes		35,152		8,697		14,289		(4,273	)		53,865
2014
Net sales	$	160,217	$	176,425	$	173,537	$	-		$	510,179
Gross profit		48,496		36,615		29,592		-			114,703
Income before income taxes		19,710		17,557		13,273		(5,866	)		44,674
2013
Net sales	$	129,667	$	184,852	$	185,171	$	-		$	499,690
Gross profit		39,306		31,367		27,598		-			98,271
Income before income taxes		17,276		13,294		10,400		(6,420	)		34,550

Net sales and gross profit by source country for the years ended June 30, 2015, 2014 and 2013 were as follows:

	Net Sales						Gross Profit
	2015		2014		2013		2015		2014		2013
United States	$	407,101	$	355,715	$	326,247	$	111,734	$	82,573	$	68,964
Germany		69,889		84,024		92,053		14,660		22,614		19,688
Netherlands		14,656		14,869		14,513		1,325		1,581		1,693
France		27,976		29,412		38,475		3,634		4,182		4,608
Asia-Pacific		27,329		26,159		28,402		4,081		3,753		3,318
Total	$	546,951	$	510,179	$	499,690	$	135,434	$	114,703	$	98,271

Sales generated from the United States to foreign countries amounted to $38,295, $31,156 and $36,976 for the fiscal years ended June 30, 2015, 2014 and 2013, respectively.

Long-lived assets by geographic region as of June 30, 2015 and June 30, 2014 were as follows:

	Long-lived assets
	2015		2014
United States	$	152,886	$	160,544
Europe		2,544		3,458
Asia-Pacific		1,893		2,042
Total	$	157,323	$	166,044